α-Ethyltryptamine
| αET | |
|---|---|
| Salts [] | |
|---|---|
| α-Ethyltryptamine hydrochloride | |
| α-Ethyltryptamine acetate | |
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 188.27 g/mol [1] |
| Melting point | 221 [1] |
| Solubility | 510 mg/L [1] |
| Predicted LogP | 2.5 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C12H16N2 |
| IUPAC name | 1-(1H-indol-3-yl)butan-2-amine |
| SMILES | CCC(CC1=CNC2=CC=CC=C21)N |
| InChI | InChI=1S/C12H16N2/c1-2-10(13)7-9-8-14-12-6-4-3-5-11(9)12/h3-6,8,10,14H,2,7,13H2,1H3 |
| InChIKey | ZXUMUPVQYAFTLF-UHFFFAOYSA-N |
| CAS number | 2235-90-7 |
| UNII | GR181O3R32 |
| PubChem CID | 8367 |
| Pharmacokinetics[] | |
|---|---|
| Onset | 0.5–1.5 hours |
| Elimination half-life | ~8 hours |
| Duration of action | 6–8 hours (100–150 mg) |
| Metabolism | Hydroxylation |
| Excretion | Urine (majority) |
| Routes of administration | Oral |
α-Ethyltryptamine (also known as Etryptamine, 3-(2-Aminobutyl)indole, Etriptamina, 3-Indolylbutylamine, Etryptaminum, Monase, Ro 3-1932, 1H-Indole-3-ethanamine, α-ethyl-, 2-ethyltryptamine or 3-(2-aminobutylindole)) is a entactogen and stimulant substance of the α-alkyltryptamine class.
Chemistry
Salts []
Stereochemistry []
α-Ethyltryptamine is a racemic mixture of the enantiomers (optical activity ( + / - )).
| Stereoisomerism |
|---|
| Stereoisomers from PubChem |
Druglikeness
Lipinski's rule of five
α-Ethyltryptamine matches Lipinski's rule of five.Pharmacology
Mechanism of action []
The mechanism of action responsible for its antidepressant activity was believed to lie in its ability to inhibit monoamine oxidase, while its stimulant activity on the central nervous system appeared to result from its structural similarity to indole-based psychedelics. [5] Research discovered αET to be both a monoamine oxidase inhibitor and a potent monoamine releasing agent capable of serotonergic neurotoxicity. [3] The ability to release serotonin was linked to αET's MDMA like properties. [2] αET has been shown to release serotonin pre-synaptically, as well as lesser amounts of norepinephrine and dopamine. [1]
Interactions []
Subjective effects []
Legal status []
- Brazil: α-Ethyltryptamine is a F2.[3]
- Canada: α-Ethyltryptamine is a Schedule III.
- United States: α-Ethyltryptamine is a Schedule I under the "Controlled Substances Act".
- United Kingdom: α-Ethyltryptamine is a Class A under the "Misuse of Drugs Act 1971".
- Germany: α-Ethyltryptamine is a Anlage I under the "Betäubungsmittelgesetz (BtMG)".
- United Nations: α-Ethyltryptamine is a Schedule I psychotropic under the "Convention on Psychotropic Substances 1971".
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 8367, α-Ethyltryptamine. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/8367
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. α-Ethyltryptamine. UNII: GR181O3R32. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/GR181O3R32
RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 2023-07-24. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-804-de-24-de-julho-de-2023-498447451
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 14:59:59 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 14:59:55 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 14:59:55 |
| gsrs | ok | 2026-11-20 14:59:57 |
| hmdb | missing (no HMDB id) | 2026-11-20 14:59:55 |
| kegg | ok | 2026-11-20 14:59:59 |
| pubchem | ok | 2026-11-20 14:59:53 |
| missing (no r/tripreports posts mention it) | 2026-11-20 14:59:55 | |
| sider | missing (not in SIDER) | 2026-11-20 14:59:55 |
| structure | ok | 2026-11-20 14:59:55 |
| wikipedia | ok | 2026-11-20 14:59:55 |